Company Badge
USPTO Data Jan 1 1976 - Oct 6 2026
4 Patents
#245 in Denver, CO
#1,418 in Colorado
#60,602 in US
Antriabio, Inc.
Forward Citations = 6
5 inventors:
Denver, CO, United States of America
Antriabio, Inc.
% Expired Patents = 100.0
EPO Patents = 2
Forward Citations = 6
Loading Chart...
Loading Chart...
5 inventors (with patents filed for the assignee):
Greg Bryden Sebring (2 out of 3 patents)
Danny H Lewis (2 out of 30 patents)
Kenneth Hinds (2 out of 3 patents)
4. Kathleen M Campbell (2 out of 3 patents)
5. Paul J Schmidt (2 out of 78 patents)
4 patents:
Company Overview
Antriabio, Inc. is a biotechnology company focused on developing innovative therapies for the treatment of cancer and autoimmune diseases. The company's pipeline includes novel small molecule drugs with strong potential to address unmet medical needs. Antriabio's mission is to improve patient outcomes and quality of life through cutting-edge research and development.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Antriabio, Inc.. Retrieved from https://idiyas.com/company/antriabio
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]